Jay Rappaport

Genomic analysis of Fas and FasL genes and absence of correlation with disease progression in AIDS

G. Lathrop, J. Zagury, G. Diop, 2004, Immunogenetics.

HIV and complement: hijacking an immune defense.

P. Datta, J. Rappaport, Jay Rappaport, 2006, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Role of HIV-1 Tat and CC chemokine MIP-1alpha in the pathogenesis of HIV associated central nervous system disorders.

S. Croul, K. Khalili, S. Morgello, 1999, Journal of neurovirology.

Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine.

W. Blattner, A. Burny, J. Zagury, 1998, Journal of human virology.

Contribution of cohort studies in understanding HIV pathogenesis: introduction of the GRIV cohort and preliminary results.

J. Zagury, F. Schächter, J. Rappaport, 1996, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Tat toxoid as a component of a preventive vaccine in seronegative subjects.

A. Burny, E. Santagostino, J. Zagury, 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

C-C chemokines, pivotal in protection against HIV type 1 infection.

S. O’Brien, A. Burny, E. Santagostino, 1998, Proceedings of the National Academy of Sciences of the United States of America.